Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Ocular Therapeutix, Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 132 | 4 | 123 | −5 |
| Shares | 43.5M | 146.3K | 44.3M | +943.8K (+2.2%) |
| Value | $215.4M | $725.0K | $178.2M | −$36.5M (−17.0%) |
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Ocular Therapeutix, Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MSD Partners, L.P. | 1,016,302 | $4.09M | 0.31% |
| Banco Santander, S.A. | 555,884 | $2.23M | 0.03% |
| UBS Oconnor LLC | 512,886 | $2.06M | 0.02% |
| Levin Capital Strategies, L.P. | 132,654 | $533.0K | 0.06% |
| Tudor Investment Corp Et Al | 51,039 | $205.0K | 0.01% |
| Point72 Asset Management, L.P. | 50,000 | $201.0K | 0.00% |
| Jane Street Group, LLC | 46,944 | $189.0K | 0.00% |
| Fred Alger Management, LLC | 45,987 | $185.0K | 0.00% |
| Squarepoint Ops LLC | 36,891 | $148.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 23,592 | $95.0K | 0.00% |
| Balyasny Asset Management LLC | 18,459 | $74.0K | 0.00% |
| Acuta Capital Partners, LLC | 13,171 | $53.0K | 0.03% |
| SG Americas Securities, LLC | 10,094 | $41.0K | 0.00% |
| Point72 Hong Kong Ltd | 4,162 | $17.0K | 0.00% |
| Founders Capital Management | 2,500 | $10.0K | 0.01% |
| EverSource Wealth Advisors, LLC | 906 | $4.00K | 0.00% |
Sold out (21)
Institutions that held Ocular Therapeutix, Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Two Sigma Investments, LP | 483,284 | $2.39M |
| Voloridge Investment Management, LLC | 174,967 | $866.0K |
| Swiss National Bank | 172,100 | $852.0K |
| UBS Asset Management Americas Inc | 101,123 | $500.6K |
| Trexquant Investment LP | 71,224 | $353.0K |
| Credit Suisse AG | 61,043 | $302.0K |
| Polar Capital Holdings Plc | 37,790 | $187.0K |
| Ikarian Capital, LLC | 29,644 | $147.0K |
| Arizona State Retirement System | 19,673 | $97.0K |
| Ergoteles LLC | 16,945 | $84.0K |
| Walleye Capital LLC | 15,482 | $77.0K |
| Teacher Retirement System of Texas | 14,884 | $74.0K |
| Janus Henderson Group PLC | 13,076 | $64.0K |
| ExodusPoint Capital Management, LP | 11,306 | $56.0K |
| Provident Investment Management, Inc. | 10,850 | $54.0K |
| HRT Financial LP | 10,370 | $51.0K |
| Macquarie Group Ltd | 8,837 | $44.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 8,044 | $40.0K |
| Shell Asset Management Co | 5,956 | $29.0K |
| Great West Life Assurance Co | 4,020 | $21.0K |
| Quantbot Technologies LP | 127 | $0 |
Not filed for Q2 2022 yet (4)
Institutions that held Ocular Therapeutix, Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Virginia Retirement Systems Et Al | 53,500 | $265.0K |
| Golden State Equity Partners | 52,250 | $259.0K |
| Parametric Portfolio Associates LLC | 28,068 | $139.0K |
| Amalgamated Financial Corp. | 12,519 | $62.0K |